Chart of the Week: Alzheimer's Biomarker and Trial Landscape

This week's CotW includes the landscape of biomarkers and clinical trials for Alzheimer's disease. There is significant clustering around two biomarkers, but many interesting emerging biomarkers in clinical trials.

Gray: Disease

Blue: Biomarkers

Purple: Clinical Trials

Yellow: FDA Cleared and Approved Tests

For a larger SVG version click here.

Share this Image On Your Site

Please include attribution to amplion.com with this graphic. <a href='http://www.amplion.com/biomarker-trends/chart-of-the-week-alzheimers-biomarker-and-trial-landscape'><img src='http://cdn2.hubspot.net/hubfs/1727831/AlzGraph.png' alt='Alzheimers Biomarker and Trial Landscape' width='540px' border='0' /></a>

Chart of the Week: Alzheimer's Biomarker and Trial Landscape

Share this Image On Your Site

For a refresher on Amplion and BiomarkerBase:

Webinar:

Pharmacovigilance and Safety Biomarkers

Download our Free IVD Trends Report

Subscribe for Updates

Categories